USRE29875EExpiredUtility
Bronchodilator expectorant elixir
Priority: Aug 10, 1966Filed: Oct 31, 1977Granted: Jan 2, 1979
Est. expiryAug 10, 1986(expired)· nominal 20-yr term from priority
A61K 31/52
2
PatentIndex Score
0
Cited by
1
References
3
Claims
Abstract
A bronchodilator expectorant composition containing a sympathomimetic amine bronchodilator, the xanthine bronchodilator theophylline, guaiacol or a water soluble form thereof and a sedative.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A bronchodilator-expectorant composition comprised of a solution containing at least 40% by volume of water and characterized by containing in each 5 milliliters thereof 16.6 to 175 mg. of theophylline, 7.5 to 350 mg. of glyceryl guaiacolate or an equivalent solubilizing weight of potassium guaiacol sulfonate or guaiacol, and from 1/6 to a full therapeutic dose of ephedrine, pseudoephedrine, methoxyphenamine, or protokylol, and from 2 to 35 mg. of cyclopal, aprobarbital, butabarbital, or pentobarbital .[...]. .Iadd.wherein the amount of theophylline dissolved in said solution exceeds the saturated solution amount thereof in the solvents employed in said solution, and the theophylline in solution which exceeds said saturated solution amount is solubilized and held in solution by said glyceryl guaiacolate or equivalent solubilizing weight of potassium guaiacol sulfonate or guaiacol. .Iaddend.
2. The composition of claim 1 containing up to 20% by volume of alcohol.
3. The composition of claim 1 containing 4 to 25 mg. of ephedrine hydrochloride or ephedrine sulfate and from 2 to 15 mg. of butabarbital per 5 milliliters of elixir.Join the waitlist — get patent alerts
Track USRE29875E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.